Simplifying Medical Benefit Drug Management Complexities
An integrated approach to managing medically billed specialty drugs is key to optimizing cost savings and clinical outcomes.
Mark Bini, July 20, 22Read More
Why a Home Infusion Strategy is More Important Than Ever
Growing demand and new regulations have put the onus on plan sponsors to prioritize the need for a comprehensive home infusion strategy.
Mark Bini, July 01, 22Read More
Biosimilar Approval and Adoption Challenges
Accelerating the progress of biosimilars is key to lowering drug costs and improving patient access to potentially life-saving therapies.
Harold Carter, June 10, 22Read More
Uncovering Behind-the-Scenes Challenges in Bringing Gene Therapies to Market
Patients getting access to expensive gene therapies is just one of the many challenges to bringing these sometimes life-saving drugs to market.
Mary Dorholt, PharmD, June 07, 22Read More
What Is Drug Trend and How to Manage it
Drug trend, a good annual barometer for plan sponsor who are looking to control traditional and specialty drug costs, can and should be managed to improve medication access. This topic was the foc...
Kelcey Blair, PharmD, April 21, 22Read More
Three Specialty Drug Trends to Prepare for: Biosimilars, Gene and Cell Therapies, Cancer Drugs
Biosimilars, gene and cell therapies, and cancer drugs are filling the specialty pipeline. Here are some insights for each category to help you stay informed. This topic was the focus of a breakout...
Harold Carter, April 20, 22Read More